Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT03228082
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose device feasibility
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT03228082
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT03228082. Randomized; no masking; primary purpose device feasibility. Start 2017-07-13 (actual); primary completion 2019-12-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study
- Acronym
- BP-PRESELF
- Condition
- Preeclampsia
- Condition
- Cardiovascular Risk Factor
- Condition
- Cardiovascular Diseases
- Condition
- Hypertension
- Intervention (Device)
- Home Blood Pressure Monitoring (HBPM)
- Lead sponsor
- Radboud University Medical Center
- Collaborator
- Interreg
Record details
- Record id
cardio:ct-nct03228082- Content hash
6026bd3cc3ec402921a4dd31b6cd450883595eaa3e6563b67f1a04e00d2be656